Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1501-1510 of 1,873) with videos related to

Pageof 188
Sort By:
European Heart Journal|April 21, 2017
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trialsAzmil H Abdul-Rahim, Ana-Cristina Perez, Rachael L MacIsaac, et al.
Circulation. Heart Failure|January 13, 2016
Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure TrialSøren L Kristensen, David Preiss, Pardeep S Jhund, et al.
Journal of the American Heart Association|February 1, 2021
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HFSolmaz Ehteshami-Afshar, Leanne Mooney, Pooja Dewan, et al.
Cureus|September 29, 2022
Forming Cardi-OH: A Statewide Collaborative to Improve Cardiovascular Health in OhioShari D Bolen, Elizabeth A Beverly, Shireen Khoury, et al.
European Heart Journal|March 24, 2022
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trialScott D Solomon, Brian L Claggett, Zi Michael Miao, et al.
Lancet (London, England)|March 8, 2023
Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
Journal of the American College of Cardiology|July 30, 2025
Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection FractionKyung H Min, Alan S Go, Keane Lee, et al.
European Heart Journal|January 28, 2025
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trialAlexander Peikert, Muthiah Vaduganathan, Brian L Claggett, et al.
The Lancet. Diabetes & Endocrinology|January 16, 2025
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.
The Lancet. Digital Health|December 5, 2021
Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort studyJasper Tromp, Paul J Seekings, Chung-Lieh Hung, et al.
Pageof 188

Showing results (1501-1510 of 1,873) with videos related to

Sort By:
Pageof 188
European Heart Journal|April 21, 2017
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trialsAzmil H Abdul-Rahim, Ana-Cristina Perez, Rachael L MacIsaac, et al.
Circulation. Heart Failure|January 13, 2016
Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure TrialSøren L Kristensen, David Preiss, Pardeep S Jhund, et al.
Journal of the American Heart Association|February 1, 2021
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HFSolmaz Ehteshami-Afshar, Leanne Mooney, Pooja Dewan, et al.
Cureus|September 29, 2022
Forming Cardi-OH: A Statewide Collaborative to Improve Cardiovascular Health in OhioShari D Bolen, Elizabeth A Beverly, Shireen Khoury, et al.
European Heart Journal|March 24, 2022
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trialScott D Solomon, Brian L Claggett, Zi Michael Miao, et al.
Lancet (London, England)|March 8, 2023
Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
Journal of the American College of Cardiology|July 30, 2025
Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection FractionKyung H Min, Alan S Go, Keane Lee, et al.
European Heart Journal|January 28, 2025
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trialAlexander Peikert, Muthiah Vaduganathan, Brian L Claggett, et al.
The Lancet. Diabetes & Endocrinology|January 16, 2025
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.
The Lancet. Digital Health|December 5, 2021
Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort studyJasper Tromp, Paul J Seekings, Chung-Lieh Hung, et al.
Pageof 188